Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™.

The SYNERGY™ stent demonstrates favorable clinical efficacy and safety outcome data, whilst the clinical data on MEGATRON™ are sparse, but early data are promising. The specific overexpansion capabilities, visibility and radial strength of the MEGATRON™ are attractive features for complex coronary interventions.